MicroRNAs in Metabolism

Sara Vienberg, Julian Geiger, Søren Madsen, Louise Torp Dalgaard

Publikation: Bidrag til tidsskriftReviewForskningpeer review

Resumé

MicroRNAs (miRNAs) have within the past decade emerged as key regulators of metabolic homoeostasis. Major tissues in intermediary metabolism important during development of the metabolic syndrome, such as β-cells, liver, skeletal and heart muscle as well as adipose tissue, have all been shown to be affected by miRNAs. In the pancreatic β-cell, a number of miRNAs are important in maintaining the balance between differentiation and proliferation (miR-200 and miR-29 families) and insulin exocytosis in the differentiated state is controlled by miR-7, miR-375 and miR-335. MiR-33a and MiR-33b play crucial roles in cholesterol and lipid metabolism, whereas miR-103 and miR-107 regulates hepatic insulin sensitivity. In muscle tissue, a defined number of miRNAs (miR-1, miR-133, miR-206) control myofibre type switch and induce myogenic differentiation programmes. Similarly, in adipose tissue, a defined number of miRNAs control white to brown adipocyte conversion or differentiation (miR-365, miR-133, miR-455). The discovery of circulating miRNAs in exosomes emphasizes their importance as both endocrine signalling molecules and potentially disease markers. Their dysregulation in metabolic diseases, such as obesity, type 2 diabetes and atherosclerosis stresses their potential as therapeutic targets. This review emphasizes current ideas and controversies within miRNA research in metabolism
OriginalsprogEngelsk
TidsskriftActa Physiologica
Vol/bind219
Udgave nummer2
Sider (fra-til)346-361
Antal sider16
ISSN1748-1708
DOI
StatusUdgivet - jan. 2017

Citer dette

Vienberg, S., Geiger, J., Madsen, S., & Dalgaard, L. T. (2017). MicroRNAs in Metabolism. Acta Physiologica, 219(2), 346-361. https://doi.org/10.1111/apha.12681
Vienberg, Sara ; Geiger, Julian ; Madsen, Søren ; Dalgaard, Louise Torp. / MicroRNAs in Metabolism. I: Acta Physiologica. 2017 ; Bind 219, Nr. 2. s. 346-361.
@article{4b25eb8995334305a33af0b488cc3903,
title = "MicroRNAs in Metabolism",
abstract = "MicroRNAs (miRNAs) have within the past decade emerged as key regulators of metabolic homoeostasis. Major tissues in intermediary metabolism important during development of the metabolic syndrome, such as β-cells, liver, skeletal and heart muscle as well as adipose tissue, have all been shown to be affected by miRNAs. In the pancreatic β-cell, a number of miRNAs are important in maintaining the balance between differentiation and proliferation (miR-200 and miR-29 families) and insulin exocytosis in the differentiated state is controlled by miR-7, miR-375 and miR-335. MiR-33a and MiR-33b play crucial roles in cholesterol and lipid metabolism, whereas miR-103 and miR-107 regulates hepatic insulin sensitivity. In muscle tissue, a defined number of miRNAs (miR-1, miR-133, miR-206) control myofibre type switch and induce myogenic differentiation programmes. Similarly, in adipose tissue, a defined number of miRNAs control white to brown adipocyte conversion or differentiation (miR-365, miR-133, miR-455). The discovery of circulating miRNAs in exosomes emphasizes their importance as both endocrine signalling molecules and potentially disease markers. Their dysregulation in metabolic diseases, such as obesity, type 2 diabetes and atherosclerosis stresses their potential as therapeutic targets. This review emphasizes current ideas and controversies within miRNA research in metabolism",
keywords = "adipocytes, metabolism, MicroRNA, non-alcoholic hepato-steatosis, type 2 diabetes mellitus, β-cells",
author = "Sara Vienberg and Julian Geiger and S{\o}ren Madsen and Dalgaard, {Louise Torp}",
year = "2017",
month = "1",
doi = "10.1111/apha.12681",
language = "English",
volume = "219",
pages = "346--361",
journal = "Acta Physiologica (Print)",
issn = "1748-1708",
publisher = "Wiley-Blackwell Publishing Ltd.",
number = "2",

}

Vienberg, S, Geiger, J, Madsen, S & Dalgaard, LT 2017, 'MicroRNAs in Metabolism', Acta Physiologica, bind 219, nr. 2, s. 346-361. https://doi.org/10.1111/apha.12681

MicroRNAs in Metabolism. / Vienberg, Sara; Geiger, Julian; Madsen, Søren; Dalgaard, Louise Torp.

I: Acta Physiologica, Bind 219, Nr. 2, 01.2017, s. 346-361.

Publikation: Bidrag til tidsskriftReviewForskningpeer review

TY - JOUR

T1 - MicroRNAs in Metabolism

AU - Vienberg, Sara

AU - Geiger, Julian

AU - Madsen, Søren

AU - Dalgaard, Louise Torp

PY - 2017/1

Y1 - 2017/1

N2 - MicroRNAs (miRNAs) have within the past decade emerged as key regulators of metabolic homoeostasis. Major tissues in intermediary metabolism important during development of the metabolic syndrome, such as β-cells, liver, skeletal and heart muscle as well as adipose tissue, have all been shown to be affected by miRNAs. In the pancreatic β-cell, a number of miRNAs are important in maintaining the balance between differentiation and proliferation (miR-200 and miR-29 families) and insulin exocytosis in the differentiated state is controlled by miR-7, miR-375 and miR-335. MiR-33a and MiR-33b play crucial roles in cholesterol and lipid metabolism, whereas miR-103 and miR-107 regulates hepatic insulin sensitivity. In muscle tissue, a defined number of miRNAs (miR-1, miR-133, miR-206) control myofibre type switch and induce myogenic differentiation programmes. Similarly, in adipose tissue, a defined number of miRNAs control white to brown adipocyte conversion or differentiation (miR-365, miR-133, miR-455). The discovery of circulating miRNAs in exosomes emphasizes their importance as both endocrine signalling molecules and potentially disease markers. Their dysregulation in metabolic diseases, such as obesity, type 2 diabetes and atherosclerosis stresses their potential as therapeutic targets. This review emphasizes current ideas and controversies within miRNA research in metabolism

AB - MicroRNAs (miRNAs) have within the past decade emerged as key regulators of metabolic homoeostasis. Major tissues in intermediary metabolism important during development of the metabolic syndrome, such as β-cells, liver, skeletal and heart muscle as well as adipose tissue, have all been shown to be affected by miRNAs. In the pancreatic β-cell, a number of miRNAs are important in maintaining the balance between differentiation and proliferation (miR-200 and miR-29 families) and insulin exocytosis in the differentiated state is controlled by miR-7, miR-375 and miR-335. MiR-33a and MiR-33b play crucial roles in cholesterol and lipid metabolism, whereas miR-103 and miR-107 regulates hepatic insulin sensitivity. In muscle tissue, a defined number of miRNAs (miR-1, miR-133, miR-206) control myofibre type switch and induce myogenic differentiation programmes. Similarly, in adipose tissue, a defined number of miRNAs control white to brown adipocyte conversion or differentiation (miR-365, miR-133, miR-455). The discovery of circulating miRNAs in exosomes emphasizes their importance as both endocrine signalling molecules and potentially disease markers. Their dysregulation in metabolic diseases, such as obesity, type 2 diabetes and atherosclerosis stresses their potential as therapeutic targets. This review emphasizes current ideas and controversies within miRNA research in metabolism

KW - adipocytes

KW - metabolism

KW - MicroRNA

KW - non-alcoholic hepato-steatosis

KW - type 2 diabetes mellitus

KW - β-cells

U2 - 10.1111/apha.12681

DO - 10.1111/apha.12681

M3 - Review

VL - 219

SP - 346

EP - 361

JO - Acta Physiologica (Print)

JF - Acta Physiologica (Print)

SN - 1748-1708

IS - 2

ER -

Vienberg S, Geiger J, Madsen S, Dalgaard LT. MicroRNAs in Metabolism. Acta Physiologica. 2017 jan;219(2):346-361. https://doi.org/10.1111/apha.12681